Evaluation of the Care Provided to Patients Who Underwent Bariatric Surgery and Were Lost to Follow-up 5 Years After Surgery
NCT ID: NCT07118540
Last Updated: 2025-08-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
176 participants
OBSERVATIONAL
2025-06-01
2025-10-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
However, it causes various deficiencies, such as vitamin and iron deficiencies, which justify lifelong personalised vitamin supplementation and, consequently, lifelong medical supervision. The latest recommendations from the French National Authority for Health (Haute Autorité de Santé) clearly state that patients must commit to lifelong medical follow-up after bariatric surgery. (HAS, February 2024, R94). R94. Regular biological monitoring after bariatric surgery is recommended: three times in the first year and then once or twice a year thereafter.
Within the OBESEPI cohort (clinical trial number NCT02663388), which comprises patients who underwent surgery at Nancy University Hospital between 2013 and 2018, we observed that over 50% of patients were lost to follow-up five years after surgery.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Dietary Supplement Refill Bypass to Reduce Nutritional Deficiencies of Patients Who Underwent Bariatric Surgery
NCT02440087
Trajectories of Resilience and Bariatric Surgery Outcomes
NCT05341414
Outcome of Bariatric Surgery in Patients With BMI Greater Than 60 .
NCT04663425
Study of Bariatric Surgery
NCT02857179
Nutritional Health and Satisfaction After Bariatric Surgery: a Five-Year Retrospective Study
NCT06664580
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients with obesity who met the HAS (French high health authority) criteria for surgical treatment were recruited.
This corresponds to patients with a BMI \> 35 kg/m2 with obesity-related complications (hypertension and/or diabetes and/or dyslipidemia and/or obstructive apnea syndrom ) and patients with a BMI \> 40 with or without obesity-related complications.
These patients, who were candidates for scheduled bariatric surgery, were recruited by a surgeon involved in the protocol during preoperative consultations in the Metabolic, Visceral and oncologic department of surgery ; Department at Nancy University Hospital; between 2013 and 2018 (the OBESEPI-ALDEPI cohort - clinical trial NCT02663388) ). All patients met the HAS's eligibility criteria previously cited for bariatric surgery.
Two groups could be studied:
Patients who underwent surgery and were lost to follow-up five years after after bariatric surgery
The second group comprised patients who underwent surgery and were still being monitored at Nancy University Hospital five years after their inclusion.
Patients were considered lost to follow-up if there was no record of them visiting the Metabolic, Visceral and oncologic department of surgery five years after their inclusion, as determined using the DXCare software (which contain medical file).
A questionnaire is used to collect all data. This is completed by telephone or sent by email to patients who have been lost to follow-up.
This questionnaire contains questions designed to help us achieve the main and secondary objectives described in the dedicated section.
Statistical analysis :
All data will be presented as numbers and percentages for qualitative variables, and as means, standard deviations, medians, quartiles, and extreme values for quantitative variables.
The characteristics of patients lost to follow-up from the OBESPI cohort will be compared with those still being followed up using Fisher's exact test, Chi-squared test or Wilcoxon's rank sum test.
To meet the objectives, these tests will also be used to compare patients lost to follow-up with those still being followed.
Assessment of research benefits:
Methods for monitoring patients lost to follow-up should be assessed in order to develop training for general practitioners in the Lorraine region, enabling them to provide appropriate follow-up care to patients who have undergone bariatric surgery.
Train general practitioners to prevent nutritional complications of bariatric surgery.
Train general practitioners to recognise the warning signs that require referral to a specialist centre.
There is major interest in improving healthcare practices, given that 60,000 bariatric surgeries are performed annually in France, with 800,000 patients having undergone surgery in 2019.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Individuals who have received complete information about the organisation of the research and have not objected to their participation and the use of their data;
* Affiliation with a social security scheme.
Exclusion Criteria
* Pregnant and breastfeeding women;
* Patients under legal guardianship or curatorship;
* Patients deprived of their liberty by a judicial or administrative decision.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
NOMINE-CRIQUI Claire
Staff surgeon in Visceral Metabolic and oncologic surgery department, head of the endocrine surgery Unit
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Universitaire de Nancy
Nancy, Lorraine, France
Centre Hospitalier Universitaire de Nancy
Nancy, Lorraine, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
(1)Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 Lancet. 2025 Mar 8; (2)Peirson L, Douketis J, Ciliska D, Fitzpatrick-Lewis D, Ali MU, Raina P. Treatment for overweight and obesity in adult populations: a systematic review and meta-analysis. CMAJ Open. Oct 2014;2(4):E306-317. (3)Jackson VM, Breen DM, Fortin JP, et al. Latest approaches for the treatment of obesity. Expert opinion on drug discovery. 2015;10(8):825-839. (4)Recommandation HAS février 2024 : Prise en charge de l'obésité de niveau 2 et 3 https://www.has-sante.fr/upload/docs/application/pdf/2024-02/reco369_recommandations_obesite_2e_3e_niveaux_ii_cd_2024_02_08_preparation_mel.pdf (5)Chirurgie bariatrique : état des lieux en France en 2019 Halimi et al Médecine des maladies Métaboliques
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16062025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.